{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-067476","form_type":"8-K","ticker":"CRDF","cik":"0001213037","company_name":"Cardiff Oncology, Inc.","filed_at":"2026-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.656304+00:00","generated_at":"2026-05-16T00:40:55.206595+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Cardiff Oncology reports Phase 2 mCRC data: ORR 72.2% vs 43.2% SoC, PFS HR 0.37; plans registrational program","bullets":["Phase 2 CRDF-004: ORR 72.2% vs 43.2% combined SoC; PFS HR 0.37 (p<0.05) for 30 mg onvansertib + FOLFIRI/bev in first-line RAS-mutated mCRC.","Plans to advance 30 mg dose into registrational program; detailed data and FDA discussions expected H1 2026.","Cash $58.3M as of Dec 31, 2025; funds operations into Q1 2027. Total op ex $49.6M, slight increase from $49.3M in 2024.","Executive changes: Mani Mohindru appointed interim CEO; Brigitte Lindsay promoted to CAO; search for permanent CEO/CFO ongoing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-067476","json":"https://secwatch.observer/filing/0001193125-26-067476.json","markdown":"https://secwatch.observer/filing/0001193125-26-067476.md","text":"https://secwatch.observer/filing/0001193125-26-067476.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1213037/000119312526067476/0001193125-26-067476-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1213037/000119312526067476/crdf-20260224.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T00:40:55.206595+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}